Back to HomeBeta

ICD-10 Coding for Superficial Esophageal Carcinoma with Hyperparathyroidism(C15.5, E21.1)

Complete ICD-10-CM coding and documentation guide for Superficial Esophageal Carcinoma with Hyperparathyroidism. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Esophageal Cancer with Secondary HyperparathyroidismEsophageal SCC with Hypercalcemia

Related ICD-10 Code Ranges

Complete code families applicable to Superficial Esophageal Carcinoma with Hyperparathyroidism

C15-C15.9Primary Range

Malignant neoplasm of esophagus

Primary code range for esophageal carcinoma, including superficial types.

Hyperparathyroidism and other disorders of parathyroid gland

Includes secondary hyperparathyroidism due to malignancy.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C15.5Malignant neoplasm of lower third of esophagusUse when esophageal carcinoma is confirmed in the lower third of the esophagus.
  • Histological confirmation of esophageal carcinoma
  • Imaging studies showing tumor location
E21.1Secondary hyperparathyroidism, not elsewhere classifiedUse when hyperparathyroidism is secondary to esophageal carcinoma.
  • Elevated serum calcium and PTHrP levels
  • Documentation linking hyperparathyroidism to esophageal carcinoma

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for esophageal carcinoma with hyperparathyroidism

Essential facts and insights about Superficial Esophageal Carcinoma with Hyperparathyroidism

The ICD-10 code for superficial esophageal carcinoma is C15.5, and for secondary hyperparathyroidism due to malignancy, it is E21.1.

Primary ICD-10-CM Codes for superficial esophageal carcinoma hyperparathyroidism

Malignant neoplasm of lower third of esophagus
Billable Code

Decision Criteria

clinical Criteria

  • Histological confirmation of carcinoma in the lower third of the esophagus

Applicable To

  • Superficial esophageal carcinoma

Excludes

  • Benign neoplasm of esophagus

Clinical Validation Requirements

  • Histological confirmation of esophageal carcinoma
  • Imaging studies showing tumor location

Code-Specific Risks

  • Misclassification of tumor location

Coding Notes

  • Ensure documentation specifies the exact location of the tumor within the esophagus.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Other specified abnormal findings of blood chemistry

R79.89
Use for documenting hypercalcemia associated with the carcinoma.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of esophagus, unspecified

C15.9
Use C15.9 when the specific location within the esophagus is not documented.

Secondary hyperparathyroidism of renal origin

N25.81
Use N25.81 when hyperparathyroidism is due to renal failure.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Superficial Esophageal Carcinoma with Hyperparathyroidism to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C15.5.

Impact

Clinical: Misrepresentation of the patient's condition., Regulatory: Potential for audit and compliance issues., Financial: Denied claims due to incomplete documentation.

Mitigation Strategy

Ensure documentation explicitly links the conditions., Regular training on documentation standards.

Impact

Reimbursement: Incorrect sequencing can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Always sequence the malignancy code (C15.x) before the hyperparathyroidism code (E21.1).

Impact

Incorrect sequencing of primary and secondary codes.

Mitigation Strategy

Educate staff on proper sequencing rules and conduct regular audits.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Superficial Esophageal Carcinoma with Hyperparathyroidism, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Superficial Esophageal Carcinoma with Hyperparathyroidism

Use these documentation templates to ensure complete and accurate documentation for Superficial Esophageal Carcinoma with Hyperparathyroidism. These templates include all required elements for proper coding and billing.

Oncology Progress Note

Specialty: Oncology

Required Elements

  • Diagnosis of esophageal carcinoma
  • Laboratory results showing hypercalcemia
  • PTHrP levels
  • Treatment plan for hypercalcemia

Example Documentation

Patient diagnosed with superficial esophageal carcinoma (C15.5) presenting with hypercalcemia (E21.1). PTHrP levels elevated. Treatment initiated with IV fluids and bisphosphonates.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Esophageal cancer with high calcium.
Good Documentation Example
Moderately differentiated squamous cell carcinoma of mid-esophagus (C15.4) with PTHrP-mediated hypercalcemia (serum Ca²⁺ 12.8 mg/dL, PTHrP 7.9 pmol/L), no bone metastases identified on PET/CT.
Explanation
The good example provides specific details on the type of carcinoma, lab values, and excludes other potential causes.

Need help with ICD-10 coding for Superficial Esophageal Carcinoma with Hyperparathyroidism? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more